sanofi-aventis (SNY) To Reduce U.S. Workforce by 25%; Will Refocus U.S. Ops on Three Areas

October 8, 2010 11:08 AM EDT Send to a Friend
Get Alerts SNY Hot Sheet
Trade SNY Now!
Join SI Premium – FREE
Sanofi-aventis' (NYSE: SNY) U.S. division announced that they would be streamlining their operations in lieu of the challenging healthcare marketplace.

The restructuring will include an estimated 25% work force reduction in U.S. Pharmaceutical Operations, eliminating approximately 1,700 positions in total. These decisions will be finalized by mid-December.

Also, the focus of U.S. Pharmaceuticals will be Diabetes, Atrial Fibrillation and Oncology.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News

Add Your Comment